Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
New Nordic Healthbrands ABFRA:N9X -5.51%64 Return-on-Tangible-Asset is 10.67% as of Jun. 2026, which is 27% above its 10-year median of 8.40. GuruFocus rates FRA:N9X with a GF Score™ of 64/100 and a GF Value™ of €1.87. The stock has 4 warning signs investors should review. Among 1,994 Consumer Packaged Goods companies, New Nordic Healthbrands AB ranks worse than 53.41% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. New Nordic Healthbrands AB's annualizedNet Income for the quarter that ended in Jun. 2026 was €2.66 Mil. New Nordic Healthbrands AB's average total tangible assets for the quarter that ended in Jun. 2026 was €24.96 Mil. Therefore, New Nordic Healthbrands AB's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 10.67%.
The historical rank and industry rank for New Nordic Healthbrands AB's Return-on-Tangible-Asset or its related term are showing as below:
FRA:N9X'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3.15 Med: 8.4 Max: 17.6
Current: 3.07
During the past 13 years, New Nordic Healthbrands AB's highest Return-on-Tangible-Asset was 17.60%. The lowest was -3.15%. And the median was 8.40%.
FRA:N9X's Return-on-Tangible-Asset is ranked worse than 53.41% of 1994
companies
in the Consumer Packaged Goods industry
Industry Median: 3.53
vs FRA:N9X: 3.07
New Nordic Healthbrands AB (FRA:N9X) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
New Nordic Healthbrands AB Return-on-Tangible-Asset Related Terms
New Nordic Healthbrands AB Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Nordic Healthbrands AB Return-on-Tangible-Asset Chart
FRA:N9X vs KHC, GIS, HRL: Return-on-Tangible-Asset Comparison
For the Packaged Foods subindustry, New Nordic Healthbrands AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB Return-on-Tangible-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 10.67% mean?
New Nordic Healthbrands AB (FRA:N9X) has a Return-on-Tangible-Asset of 10.67% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on New Nordic Healthbrands AB and its competitors. This is 27% above median its historical median of 8.40. According to the industry distribution chart, New Nordic Healthbrands AB ranks #1065 out of 1994 companies in the Consumer Packaged Goods industry, placing it in the top 53.4%.
Is New Nordic Healthbrands AB's Return-on-Tangible-Asset too high?
New Nordic Healthbrands AB's current Return-on-Tangible-Asset of 10.67% is 27% above median its 10-year median of 8.40. The Consumer Packaged Goods industry median Return-on-Tangible-Asset is 3.53. New Nordic Healthbrands AB's value of 10.67% is 202.3% above this industry median. Based on the distribution chart, New Nordic Healthbrands AB ranks #1065 out of 1994 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, New Nordic Healthbrands AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's Return-on-Tangible-Asset compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #1065 out of 1994 companies for Return-on-Tangible-Asset. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.53. New Nordic Healthbrands AB's value of 10.67% is 202.3% above this benchmark. While the company's 10-year median is 8.40 vs. the industry median of 3.53, New Nordic Healthbrands AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.53, based on 1,994 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. New Nordic Healthbrands AB's current Return-on-Tangible-Asset of 10.67% is 202.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current Return-on-Tangible-Asset is 10.67%, which is 27% above median its own 10-year median of 8.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current Return-on-Tangible-Asset of 10.67%. The stock's GF Value™ is €1.87, compared to a current price of €1.63 — trading 12.8% below its estimated fair value. The current Return-on-Tangible-Asset is 10.67%, which is 27% above median its 10-year median of 8.40 and 202.3% above the Consumer Packaged Goods industry median of 3.53. New Nordic Healthbrands AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current Return-on-Tangible-Asset is 10.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.63 is trading 12.8% below its estimated GF Value™ of €1.87.
Key valuation signals for FRA:N9X:
Return-on-Tangible-Asset: 10.67% (27% above median its 10-year median of 8.40)
GF Value™: €1.87 vs. price of €1.63 (12.8% below fair value)
Industry Position: 202.3% above the Consumer Packaged Goods median (#1065 of 1994)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
64GF Score
Get the complete analysis for FRA:N9X
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
